Literature DB >> 15914619

Selective upregulation of the A3 adenosine receptor in eyes with pseudoexfoliation syndrome and glaucoma.

Ursula Schlötzer-Schrehardt1, Matthias Zenkel, Ulrich Decking, Daniela Haubs, Friedrich E Kruse, Anselm Jünemann, Miguel Coca-Prados, Gottfried O H Naumann.   

Abstract

PURPOSE: Adenosine is increasingly released in metabolic stress conditions, like hypoxia or ischemia, and regulates many physiologic processes, such as aqueous humor secretion and intraocular pressure, via activation of four adenosine receptors. In the current study, the role of the adenosine system in the pathophysiology of pseudoexfoliation (PEX) syndrome, which is typically associated with anterior chamber hypoxia and elevated intraocular pressure, was examined.
METHODS: RT-PCR, Northern hybridization, in situ hybridization, and immunohistochemistry were applied to analyze the mRNA and protein expression of the adenosine receptor subtypes A1, A2A, A2B, and A3 in anterior segment tissues of PEX eyes, without and with glaucoma, in comparison to eyes with primary open-angle or angle-closure glaucoma and normal control eyes. Real-time PCR was used to study the effect of hypoxia and oxidative stress on adenosine receptor expression by nonpigmented ciliary epithelial cells in vitro. Levels of adenosine and its catabolites inosine, hypoxanthine, and xanthine were measured in cell culture supernatants and aqueous humor samples by HPLC.
RESULTS: All four adenosine receptor subtypes (A2A > A1 > A2B > A3) were coexpressed but differently distributed in the ciliary epithelium of control eyes, with the A3 receptor being localized to the basolateral membrane infoldings of the nonpigmented epithelial cells. A selective, approximately 10-fold upregulation of A3 receptor mRNA and protein was consistently found in the nonpigmented ciliary epithelium of all PEX eyes, with and without glaucoma, compared with the normal and glaucomatous control eyes. Significant upregulation of A3 receptor message in nonpigmented epithelial cells was induced by both hypoxia and oxidative stress in vitro, together with increased levels of inosine, hypoxanthine, and xanthine in the supernatants. Levels of adenosine and its catabolites, however, were not significantly elevated in the aqueous humor of patients with PEX.
CONCLUSIONS: Considering the known role of the A3 adenosine receptor in modulating aqueous humor secretion, its selective, probably hypoxia-induced upregulation in the ciliary epithelium may not only confer cytoprotection but also influence aqueous humor dynamics and may be accessible to therapeutic intervention in patients with PEX.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15914619     DOI: 10.1167/iovs.04-0915

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  17 in total

1.  Cell-specific differential modulation of human trabecular meshwork cells by selective adenosine receptor agonists.

Authors:  Mike O Karl; Kim Peterson-Yantorno; Mortimer M Civan
Journal:  Exp Eye Res       Date:  2006-10-30       Impact factor: 3.467

2.  Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101.

Authors:  Sara Bar-Yehuda; Dror Luger; Avivit Ochaion; Shira Cohen; Renana Patokaa; Galina Zozulya; Phyllis B Silver; Jose Maria Garcia Ruiz de Morales; Rachel R Caspi; Pnina Fishman
Journal:  Int J Mol Med       Date:  2011-07-19       Impact factor: 4.101

3.  Human brain endothelial cells are responsive to adenosine receptor activation.

Authors:  Jeffrey H Mills; Leah Alabanza; Babette B Weksler; Pierre-Olivier Couraud; Ignacio A Romero; Margaret S Bynoe
Journal:  Purinergic Signal       Date:  2011-02-17       Impact factor: 3.765

Review 4.  Ocular Purine Receptors as Drug Targets in the Eye.

Authors:  Kenneth A Jacobson; Mortimer M Civan
Journal:  J Ocul Pharmacol Ther       Date:  2016-08-30       Impact factor: 2.671

Review 5.  Pharmacological and therapeutic effects of A3 adenosine receptor agonists.

Authors:  Pnina Fishman; Sara Bar-Yehuda; Bruce T Liang; Kenneth A Jacobson
Journal:  Drug Discov Today       Date:  2011-10-19       Impact factor: 7.851

6.  The cross-species A3 adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure.

Authors:  Hui Yang; Marcel Y Avila; Kim Peterson-Yantorno; Miguel Coca-Prados; Richard A Stone; Kenneth A Jacobson; Mortimer M Civan
Journal:  Curr Eye Res       Date:  2005-09       Impact factor: 2.424

7.  Endogenous production of extracellular adenosine by trabecular meshwork cells: potential role in outflow regulation.

Authors:  Jing Wu; Guorong Li; Coralia Luna; Ivan Spasojevic; David L Epstein; Pedro Gonzalez
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-01       Impact factor: 4.799

8.  Genome-wide expression profile of human trabecular meshwork cultured cells, nonglaucomatous and primary open angle glaucoma tissue.

Authors:  Paloma B Liton; Coralia Luna; Pratap Challa; David L Epstein; Pedro Gonzalez
Journal:  Mol Vis       Date:  2006-07-12       Impact factor: 2.367

Review 9.  Genomic and proteomic pathophysiology of pseudoexfoliation glaucoma.

Authors:  Luis E Vazquez; Richard K Lee
Journal:  Int Ophthalmol Clin       Date:  2014

10.  Restoration of lysosomal pH in RPE cells from cultured human and ABCA4(-/-) mice: pharmacologic approaches and functional recovery.

Authors:  Ji Liu; Wennan Lu; David Reigada; Jonathan Nguyen; Alan M Laties; Claire H Mitchell
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.